Identify Dry Eye Inflammation with INFLAMMADRY®

 

InflammaDry® is the first and only, rapid, in-office test that detects MMP-9, an inflammatory marker that is consistently elevated in the tears of patients with dry eye disease.1 Using direct sampling microfiltration technology, InflammaDry® accurately identifies elevated levels of MMP-9 protein in tear fluid samples taken from the inside lining of the lower eyelid, the palpebral conjunctiva.

 

InflammaDry® is a disposable, low cost test, that requires no additional equipment to administer or interpret results. Using four simple steps, InflammaDry® test results are achieved in just 10 minutes, aiding in the diagnosis of dry eye before the patient leaves the office.

 

By implementing InflammaDry® into your practice, you can:

  • Make a rapid, accurate diagnosis before the patient leaves your office

  • Reduce complications associated with dry eye

  • Help improve clinical outcomes and patient quality of life3

  • Identify and treat dry eye disease perioperatively for better surgical outcomes4

 

[1] Chotikavanich S, de Paiva CS, Li de Q, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3203-9. [2] RPS InflammaDry sensitivity and specificity was compared to clinical truth in RPS clinical study : protocol # 100310. [3] Schiffman RM, Walt JG, Jacobsen G, et al. Utility assessment among patients with dry eye disease. Ophthalmology. 2003 Jul;110(7):1412-9. [4] Sambursky R, O’Brien TP. MMP-9 and the perioperative management of LASIK surgery. Curr Opin Ophthalmol. 2011 Jul;22(4):294-303.